<VariationArchive RecordType="classified" VariationID="7055" VariationName="NM_004562.3:c.536_735del" VariationType="Deletion" Accession="VCV000007055" Version="3" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-12-09" DateCreated="2017-09-10" MostRecentSubmission="2022-12-31">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="22094" VariationID="7055">
      <GeneList>
        <Gene Symbol="PRKN" FullName="parkin RBR E3 ubiquitin protein ligase" GeneID="5071" HGNC_ID="HGNC:8607" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>6q26</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="161347417" stop="162727766" display_start="161347417" display_stop="162727766" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="161768589" stop="163148833" display_start="161768589" display_stop="163148833" Strand="-" />
          </Location>
          <OMIM>602544</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_004562.3:c.536_735del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>6q25.2-q27</CytogeneticLocation>
      </Location>
      <OtherNameList>
        <Name>EX5-6DEL</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004562.3" sequenceAccession="NM_004562" sequenceVersion="3" change="c.536_735del" MANESelect="true">
            <Expression>NM_004562.3:c.536_735del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="602544.0022" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="GenomicLocationNotEstablished">The genomic location for this variant will not be computed from alignment of the transcript sequence to the genome until there is experimental evidence for the loss of exons 5 and 6.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004562.3:c.536_735del AND Autosomal recessive juvenile Parkinson disease 2" Accession="RCV000007471" Version="6">
        <ClassifiedConditionList TraitSetID="1942">
          <ClassifiedCondition DB="MedGen" ID="C1868675">Autosomal recessive juvenile Parkinson disease 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2006-02-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2006-02-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2017-09-10" MostRecentSubmission="2022-12-31">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16476817</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1942" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3274" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Parkinson disease, juvenile, autosomal recessive</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Parkinson disease, juvenile, type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Autosomal recessive juvenile Parkinson disease 2</ElementValue>
                <XRef ID="MONDO:0010820" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Parkin Type of Juvenile Parkinson Disease</ElementValue>
                <XRef ID="NBK1478" DB="GeneReviews" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Parkinson disease autosomal recessive, early onset</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Juvenile parkinsonism</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Parkinson disease 2</ElementValue>
                <XRef ID="Parkinson+disease+2/9086" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Parkinsonism, early onset, with diurnal fluctuation</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Parkin Type of Early-Onset Parkinson Disease</ElementValue>
                <XRef ID="NBK1478" DB="GeneReviews" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PDJ</ElementValue>
                <XRef Type="MIM" ID="600116" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">JP</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PARK2</ElementValue>
                <XRef Type="MIM" ID="600116" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Parkin type of early-onset Parkinson disease (PARK-Parkin) is characterized by the cardinal signs of Parkinson disease (PD): bradykinesia, resting tremor, and rigidity. The median age at onset is 31 years (range: 3-81 years). The disease is slowly progressive: disease duration of more than 50 years has been reported. Clinical findings vary; hyperreflexia is common. Lower-limb dystonia may be a presenting sign and cognitive decline appears to be no more frequent than in the general population. Dyskinesia as a result of treatment with levodopa frequently occurs.</Attribute>
                <XRef ID="NBK1478" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9642" />
                <XRef ID="9642" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301402</ID>
                <ID Source="BookShelf">NBK1223</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301651</ID>
                <ID Source="BookShelf">NBK1478</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS/MDS-ES, 2013">
                <ID Source="PubMed">23279440</ID>
              </Citation>
              <XRef ID="2828" DB="Orphanet" />
              <XRef ID="C1868675" DB="MedGen" />
              <XRef ID="MONDO:0010820" DB="MONDO" />
              <XRef Type="MIM" ID="600116" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="27671" SubmissionDate="2017-09-07" DateLastUpdated="2022-12-31" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="602544.0022_PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE" title="PRKN, EX5-6DEL_PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE" />
        <ClinVarAccession Accession="SCV000027671" DateUpdated="2022-12-31" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2006-02-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">For discussion of the deletion of exons 5 and 6 in the PARK2 gene that was found in compound heterozygous state in sibs with early-onset Parkinson disease (PARK2; 600116) by Deng et al. (2006), see 602544.0021.</Attribute>
              <Citation>
                <ID Source="PubMed">16476817</ID>
              </Citation>
              <XRef DB="OMIM" ID="600116" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRKN" />
          </GeneList>
          <Name>PRKN, EX5-6DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">EX5-6DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="602544.0022" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="27671" TraitType="Disease" MappingType="Name" MappingValue="PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE" MappingRef="Preferred">
        <MedGen CUI="C1868675" Name="Autosomal recessive juvenile Parkinson disease 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

